VRDN
Viridian Therapeutics Inc

9,437
Mkt Cap
$2.9B
Volume
853,062.00
52W High
$34.29
52W Low
$9.90
PE Ratio
-7.44
VRDN Fundamentals
Price
$29.85
Prev Close
$28.34
Open
$28.60
50D MA
$30.81
Beta
1.08
Avg. Volume
1.44M
EPS (Annual)
-$3.32
P/B
4.89
Rev/Employee
$281,146.83
$1,947.18
Loading...
Loading...

About

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
252

Frequently Asked Questions

What is Market Cap of Viridian Therapeutics Inc?
What is the 52-week high for Viridian Therapeutics Inc?
What is the 52-week low for Viridian Therapeutics Inc?
What is Viridian Therapeutics Inc stock price today?
What was Viridian Therapeutics Inc stock price yesterday?
What is the PE ratio of Viridian Therapeutics Inc?
What is the Price-to-Book ratio of Viridian Therapeutics Inc?
What is the 50-day moving average of Viridian Therapeutics Inc?
How many employees does Viridian Therapeutics Inc have?

Latest VRDN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.